Insider Trading March 24, 2026

ON24 Executive Sells $29,536 in Stock as Deal Nears Close

EV president Jayesh Sahasi disposes 3,662 shares under 10b5-1 plan; ON24 set to be bought by Cvent for $8.10 per share

By Caleb Monroe ONTF
ON24 Executive Sells $29,536 in Stock as Deal Nears Close
ONTF

On March 20, 2026, Jayesh Sahasi, EV President, Product and CTO at ON24 Inc. (NASDAQ: ONTF), sold 3,662 shares of common stock for $29,536 under a Rule 10b5-1 plan to satisfy tax withholding from vested restricted stock units. The sale occurred as ON24 shares traded near a 52-week high amid a pending $400 million all-cash acquisition by Cvent at $8.10 per share, a deal that has prompted supplemental disclosures and shareholder litigation over proxy statement omissions.

Key Points

  • Jayesh Sahasi sold 3,662 ON24 shares on March 20, 2026, at a weighted average price of $8.0656, totaling $29,536.
  • The trades were executed under a Rule 10b5-1 plan adopted March 4, 2025, and were disclosed as actions to cover tax withholding related to vested restricted stock units.
  • ON24 has agreed to be acquired by Cvent in an all-cash deal valued at about $400 million, with shareholders receiving $8.10 per share; the deal has prompted supplemental disclosures and shareholder lawsuits.

On March 20, 2026, Jayesh Sahasi, who serves as EV President, Product and Chief Technology Officer at ON24 Inc. (NASDAQ: ONTF), executed sales totaling 3,662 shares of the company's common stock. The transactions yielded a combined value of $29,536, reflecting a weighted average sale price of $8.0656 per share.

The share disposals were carried out across multiple trades, with individual prices ranging from $8.06 to $8.075. According to the reported terms, these trades were made under a previously arranged Rule 10b5-1 trading plan that Sahasi adopted on March 4, 2025. The filings indicate the disposition of shares was intended to cover tax withholding obligations arising from the vesting of restricted stock units.

After completing the March 20 transactions, Sahasi is reported to directly own 677,132 shares of ON24. At the time of the sale, ON24's share price was trading close to its 52-week high of $8.10, following a robust six-month advance of 36%.


Separately, ON24 has secured an agreement to be acquired by Cvent in an all-cash transaction valued at approximately $400 million. Under the terms of the definitive agreement, ON24 shareholders are to receive $8.10 in cash for each share they hold. That per-share consideration was described as representing a 62% premium to the company’s closing share price on November 10, 2025, and a 51% premium to its 90-day volume-weighted average price.

The merger announcement has prompted additional company disclosures. ON24 provided supplemental information related to the proposed transaction after shareholders filed lawsuits alleging omissions in the company's definitive proxy statement. Those legal actions were filed in the Supreme Court of New York, New York County. The record also notes that demand letters and draft complaints raising analogous disclosure concerns were delivered.

While the disclosures and litigation highlight ongoing procedural and legal issues surrounding the transaction, the agreement with Cvent represents a consequential change in ownership for ON24. The company and its shareholders are proceeding through the merger process under the terms of the definitive agreement between the two parties. These developments have drawn attention from investors and market watchers tracking both insider activity and the proposed acquisition.

Risks

  • Ongoing shareholder lawsuits allege omissions in ON24's definitive proxy statement, creating legal and disclosure uncertainty that could affect timing or perceptions of the acquisition - impacting legal and corporate governance oversight sectors.
  • Supplemental disclosures indicate unresolved information questions related to the merger process, which could influence investor confidence and deal execution - relevant to M&A activity and equity markets.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026